XBIO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Xenetic Biosciences Inc (XBIO) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown significant revenue growth in its latest quarter, the lack of positive trading signals, absence of news catalysts, and the stock's current downward price movement suggest that it is better to hold off on purchasing this stock right now.
The MACD is positive and expanding, indicating some bullish momentum. However, the RSI is neutral at 65.359, and moving averages are converging, showing no clear trend. The stock is trading near its pivot level of 2.3, with resistance at 2.449 and support at 2.151. Overall, the technical indicators are mixed, with no strong buy signal.
Revenue increased by 67.19% YoY in Q3 2025, and net income improved by 16.78% YoY. Gross margin remains at 100%.
The stock price is down 2.89% in the regular market and 4.08% in the pre-market. There are no recent news catalysts, no significant hedge fund or insider trading activity, and no recent congress trading data. Additionally, the company remains unprofitable with a negative EPS of -0.33.
In Q3 2025, the company reported revenue growth of 67.19% YoY, net income improvement of 16.78% YoY, and EPS growth of 17.86% YoY. However, the company is still operating at a loss with a net income of -509,940 and an EPS of -0.33.
No data available for analyst ratings or price target changes.
